About
Technology
Issues
FAQ
Links
Official Page
Treatment beyond progression with nivolumab in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) in the phase 3 checkmate 141 study: A biomarker analysis and updated clinical outcomes
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.